Apex Biotechnology Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 4,845,346 | 4.85% |
Individual Insiders | 10,374,227 | 10.4% |
Public Companies | 11,165,000 | 11.2% |
General Public | 73,565,619 | 73.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
10,374,227 | NT$355.8m | 1.56% | no data | |||
5,806,000 | NT$199.1m | 0% | no data | |||
5,359,000 | NT$183.8m | 0% | no data | |||
1,487,649 | NT$51.0m | 6.88% | no data | |||
1,407,876 | NT$48.3m | 0% | no data | |||
1,088,829 | NT$37.3m | 0% | 100.0% | |||
784,992 | NT$26.9m | 0% | no data | |||
70,000 | NT$2.4m | 0% | no data | |||
6,000 | NT$205.7k | 0% | no data |